共 282 条
[1]
El-Serag HB(2007)Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2557-2576
[2]
Rudolph KL(2003)Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence Ann Surg 237 536-543
[3]
Ercolani G(2000)Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial Lancet 356 802-807
[4]
Grazi GL(2001)Apoptosis and the response to anticancer therapy Curr Opin Oncol 13 453-462
[5]
Ravaioli M(1995)UCN-01, an anti-tumor drug, is a selective inhibitor of the conventional PKC subfamily FEBS Lett 359 259-261
[6]
Del GM(2000)The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01 J Biol Chem 275 5600-5605
[7]
Gardini A(1997)UCN-01 in ovary cancer cells: effective as a single agent and in combination with cis-diamminedichloroplatinum(II)independent of P53 status Clin Cancer Res 3 2089-2097
[8]
Cescon M(2001)Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a P53-independent manner in human glioblastoma cells Cancer Res 61 5843-5849
[9]
Varotti G(2008)Defective P53 signaling in P53 wild-type tumors attenuates P21waf1 induction and cyclin B repression rendering them sensitive to Chk1 inhibitors that abrogate DNA damage-induced S and G2 arrest Mol Cancer Ther 7 252-262
[10]
Cetta F(2003)DNA damage-triggered apoptosis: critical role of DNA repair, double-strand breaks, cell proliferation and signaling Biochem Pharmacol 66 1547-1554